Yali Liu

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Sara A. Hurvitz, Roberto Hegg, Wei‐Pang Chung et al. · The Lancet · 2022 · 642 citations · Full text

Medicine, Oncology, Pharmacology +16

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas

Pu Wang, Qiongzhu Dong, C. Zhang et al. · Oncogene · 2012 · 389 citations

Medicine, Genetics, Oncology +14

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

Wei Zhang, Bangning Yu, Yijing He et al. · Clinica Chimica Acta · 2006 · 263 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +11

Electric-field-driven phase transition in vanadium dioxide

Boning Wu, A. Zimmers, H. Aubin et al. · Physical Review B · 2011 · 158 citations · Full text

Natural Sciences, Materials Science, Physics +17

<scp>First‐in‐human</scp> study of deucravacitinib: A selective, potent, allosteric <scp>small‐molecule</scp> inhibitor of tyrosine kinase 2

Ian M. Catlett, Urvi Aras, Lars Hansen et al. · Clinical and Translational Science · 2022 · 57 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15